Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating rosuvastatin and simvastatin when given alone or in combination with fostamatinib in rheumatoid arthritis; the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fostamatinib (fostamatinib)
  • Rosuvastatin (rosuvastatin)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED